Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Trackinsight Global ETF Survey 2026
›ETF Issuers›iShares›IYH
IYH

iShares U.S. Healthcare ETF

Passive ETFEquity

The IYH Exchange Traded Fund (ETF) is provided by iShares. It is built to track an index: Russell 1000 Health Care RIC 22.5/45 Capped Gross Index. The IYH ETF provides physical exposure, so by buying it you actually own parts of all the 101 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$77.81
+$0.26 (+0.34%) yesterday
1:30 PM 10/30/26 Closed
1D price range
$77.65$79.06
52W price range
$59.63$79.06
YTD Perf.
+20.54%
YTD Flows
Annualized volatility
Fund AuM
€4.15B
Share class AuM
€4.15B
TTM Yield
Tracking Error
Tracking Difference
ISIN
US4642877629
TER
0.37%
Inception date
6/12/2000
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Oct 30, 2026
-5%0%5%10%15%20%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 09/30/26
Healthcare
99.84%
Other
0.11%
Latest IYH news

No content available for this fund

FAQ about IYH

IYH is a passively managed ETF that invests in the US Health Care segment.
IYH tracks the Russell 1000 Health Care RIC 22.5/45 Capped Gross Index - USD, through a full replication replication method.
IYH carries a total expense ratio (TER) of 0.37%.
IYH was introduced to the market on June 12, 2000.
iShares U.S. Healthcare ETF, IYH, is provided by iShares. Learn more about iShares here.
IYH oversees €4.15B in assets as of October 30, 2026.
IYH follows a distributing dividend policy, meaning it pays out income to investors. As of October 30, 2026, its 12-month trailing yield was 1.03%.
As of September 30, 2026, IYH has significant geographic allocations in USA and Ireland.
As of September 30, 2026, IYH focuses largely on Healthcare.
As of September 30, 2026, IYH holds 101 positions in its portfolio, with 68.80% of assets concentrated in its top 15 holdings.
As of September 30, 2026, IYH top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of IYH is USD.
Data as of 09/30/26
Eli Lilly & Co.
14.55%
Johnson & Johnson
10.05%
AbbVie, Inc.
7.30%
Merck & Co., Inc.
5.66%
UnitedHealth Group, Inc.
5.22%
Thermo Fisher Scientific, Inc.
3.95%
Amgen, Inc.
3.58%
Gilead Sciences, Inc.
2.92%
Abbott Laboratories
2.70%
Pfizer Inc.
2.56%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring
Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight